NEW YORK, NY / ACCESS Newswire / December 19, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired StubHub Holdings, Inc. (NYSE:STUB) securities. If you suffered a loss on your StubHub Holdings, Inc. investment and would like to explore […]
(NasdaqGM:IOVA), SAN CARLOS, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on December 18, 2025 (the “Date of Grant”), the Company approved the grant
(TSX-V:VO),(OTC US:KVLQF),(Other OTC:KVLQF),(Boerse Frankfurt – Freiverkehr:KEQ0), VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre” or the “Company”); (TSXâ€V: VO; OTCQB: KVLQF; Frankfurt: KEQ0) today announced the voting results of its recent annual general meeting of shareholders (“AGM”), which was held on December 18, 2025. Shareholders approved setting the size of
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire December 19, 2025 SAN CARLOS, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that
ValOre Metals Corp. Announces Voting Results of Annual General Meeting GlobeNewswire December 19, 2025 VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre” or the “Company”); (TSXâ€V: VO; OTCQB: KVLQF; Frankfurt: KEQ0) today announced the voting results of its recent annual general meeting of shareholders (“AGM”), which was held on December
(TSX:VDY),(TSX:VRE),(TSX:VRIF),(TSX:VAB),(TSX:VSB),(TSX:VSC),(TSX:VCB),(TSX:VGV),(TSX:VLB),(TSX:VVSG),(TSX:VCE),(TSX:VCN),(TSX:VUN),(TSX:VUS),(TSX:VFV),(TSX:VSP),(TSX:VGG),(TSX:VGH),(TSX:VIU),(TSX:VI),(TSX:VDU),(TSX:VEF),(TSX:VIDY),(TSX:VE),(TSX:VA),(TSX:VEE),(TSX:VXC),(TSX:VBAL),(TSX:VCNS),(TSX:VGRO),(TSX:VCIP),(TSX:VEQT),(TSX:VVO),(TSX:VMO),(TSX:VVL), TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Vanguard Investments Canada Inc. today announced the estimated annual capital gains distributions for the Vanguard ETFs listed below for the 2025 tax year. This is an update to the estimated annual capital gains distributions announced on November 18, 2025. Please note that these are estimated amounts only,
Vanguard Investments Canada Announces Estimated 2025 Annual Capital Gains Distributions for the Vanguard ETFs(R) VRE, VDY, VCE, VCN, VFV, VSP, VUN, VUS, VGG, VGH, VE, VDU, VEF, VIU, VI, VEE, VA, VXC, VVO, VMO, VVL, VCNS, VBAL, VGRO, VCIP, VEQT, VIDY, VRIF, VAB, VSB, VSC, VCB, VGV, VLB and VVSG GlobeNewswire December 19, 2025 TORONTO,
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – December 19, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company“), is pleased to announce that the non-brokered private placement to raise gross proceeds of not less than US$10,000,000 (the “Offering“) previously announced on October 14, 2025 has been updated. The placement will consist
(TSX:APS),(OTC US:APTOF),(Other OTC:APTOF), SAN DIEGO and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company“) (TSX: APS; OTC: APTOF) announced today that it will be rescheduling its upcoming special meeting of shareholders, originally scheduled to be held on January 16, 2026 (the “Meeting“), to a later date to be announced.
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC GlobeNewswire December 19, 2025 SAN DIEGO and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company“) (TSX: APS; OTC: APTOF) announced today that it will be rescheduling its upcoming special